The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: a German case-control study
Abstract
Phytoestrogens are structurally similar to estrogens and may affect breast cancer risk by mimicking estrogenic/antiestrogenic properties. In Western societies, whole grains and possibly soy foods are rich sources of phytoestrogens. A population-based case-control study in German postmenopausal women was used to evaluate the association of phytoestrogen-rich foods and dietary lignans with breast cancer risk. Dietary data were collected from 2,884 cases and 5,509 controls using a validated food-frequency questionnaire, which included additional questions phytoestrogen-rich foods. Associations were assessed using conditional logistic regression. All analyses were adjusted for relevant risk and confounding factors. Polytomous logistic regression analysis was performed to evaluate the associations by estrogen receptor (ER) status. High and low consumption of soybeans as well as of sunflower and pumpkin seeds were associated with significantly reduced breast cancer risk compared to no consumption (OR = 0.83, 95% CI = 0.70-0.97; and OR = 0.66, 95% CI = 0.77-0.97, respectively). The observed associations were not differential by ER status. No statistically significant associations were found for dietary intake of plant lignans, fiber, or the calculated enterolignans. Our results provide evidence for a reduced postmenopausal breast cancer risk associated with increased consumption of sunflower and pumpkin seeds and soybeans.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Two of nine (22%) studies examining low-medium soy food/protein intake and zero of three studies examining low-medium soy isoflavone intake found inverse associations.
“On the other hand, two of nine (22%) and zero of three studies respectively found inverse associations with low-medium intake [44,71].”
From Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review (2013) · cites this paper as [44]
Of 44 case-control studies, 32 showed higher consumption of soy foods and/or soy isoflavones was associated with lower risk for primary breast cancer, breast cancer mortality, or improved markers of prognosis among the overall study population.
“Overall, of the 44 case control studies, 32 showed that higher consumption of soy foods and/ or soy isoflavones was associated with lower risk for primary breast cancer [42-46,49-51,53,54,56-58,61-64,66,71-73,75,77-79,81,83], breast cancer mortality [55], or improved markers of prognosis (ER+ status vs receptor negative status) [74,82] among the overall study population.”
From Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review (2013) · cites this paper as [44]
Among case-control studies reporting odds ratios with confidence intervals, 11 of 19 (58%) showed significant inverse relationships between soy food or protein intake and breast cancer risk.
“Of the 19 studies, 11 (58%) showed significant inverse relationships between soy food or protein intake and risk of breast cancer [44-46,61,64,71-73,77,78,81].”
From Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review (2013) · cites this paper as [44]
Cited by
Sorted by citations
Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review
Fritz, H., Seely, D., Flower, G., Skidmore, B., Fernandes, R., Vadeboncoeur, S., Kennedy, D., Cooley, K., Wong, R., Sagar, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081968 · Cited by 188 · see citing works
- Authors
- Zaineddin, A. K., Buck, K., Vrieling, A., Heinz, J., Flesch-Janys, D., Linseisen, J., & Chang-Claude, J.
- Affiliations
- German Cancer Research Center (DE)
- University Cancer Center Hamburg (DE)
- University Cancer Center Hamburg
- Helmholtz Munich (DE)
- Venue
- Nutrition and Cancer
- Publisher
- Informa UK Limited
- Published
- 2012-05-16
- Volume
- 64
- Issue
- 5
- Pages
- 652-665
- ISSN
- 0163-5581 (ISSN-L)
- 1532-7914
- OpenAlex
- W2169949840
- Cited by
- 90
- References
- 0
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 6 · 2017: 8 · 2016: 7 · 2015: 7 · 2014: 8 · 2013: 13 · 2012: 1
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nutrition and Cancer (publishedVersion)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Funders
- Deutsches Krebsforschungszentrum
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Phytoestrogen effects and research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
- Keywords
- postmenopausal breast cancer, phytoestrogens, dietary lignans, dietary fiber, soybean, sunflower seeds, pumpkin seeds, estrogen receptor status, cancer risk reduction, whole grains
- MeSH terms
- Aged, Breast Neoplasms, Carcinoma, Diet, Dietary Fiber, Female, Germany, Helianthus, Humans, Middle Aged, Risk, Seeds, Glycine max, 4-Butyrolactone, Case-Control Studies, Postmenopause, Lignans, Cucurbita, Phytoestrogens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review